Cell‐by‐cell quantification of the androgen receptor in benign and malignant prostate leads to a better understanding of changes linked to cancer initiation and progression

Abstract The androgen receptor (AR) plays a crucial role in the development and homeostasis of the prostate and is a key therapeutic target in prostate cancer (PCa). The gold standard therapy for advanced PCa is androgen deprivation therapy (ADT), which targets androgen production and AR signaling....

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Seta Derderian, Tarik Benidir, Eleonora Scarlata, Turki Altaylouni, Lucie Hamel, Fatima Zahra Zouanat, Fadi Brimo, Armen Aprikian, Simone Chevalier
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	Wiley 2023-07-01
Σειρά:	The Journal of Pathology: Clinical Research
Θέματα:	prostate cancer castration resistant prostate cancer metastasis androgen deprivation therapy androgen receptor AR
Διαθέσιμο Online:	https://doi.org/10.1002/cjp2.319
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!